Home / About VPIX / History
History
History
-
2023
-
09
-
EN ISO 13485 (TÜV Rheinland)
-
MDSAP (TÜV Rheinland)
-
-
08
-
Certification of Inno-Biz (Ministry of SEMs and Startups)
-
-
06
-
Certification of Excellent companies for job invention compensation
-
-
-
2022
-
12
-
Raised a Series Pre B2
-
-
11
-
Establishment of VPIX Medical US, Inc.
-
-
10
-
Declared Manufacturing of cCeLL - In vivo (Class 2) by MFDS (South Korea)
-
-
08
-
Secured a R&D project (Strengthening the capabilities for commercialization of medical devices) supported by the Korea Medical Device Development Fund grant funded by the Korea government
-
-
07
-
Obtained Class 2 kGMP certification
-
-
06
-
Selected as Korea representative Startups at 2022 SelectUSA Summit
-
Selected as Corporation D-Unicorn by Daejeon Metropolitan City
-
Signed MOU with College of Veterinary Medicine Chungbuk National University
-
-
04
-
Declared cCeLL – Ex vivo for CE DoC(IVDD)
-
Secured a R&D project (Leading the 4th industrial revolution and future medical environment) supported by the Korea Medical Device Development Fund grant funded by the Korea government
-
-
03
-
Registered cCeLL – Ex vivo & its manufacturing facility under FDA
-
EN ISO 13485:2016 (Immuno Cyto/Histo Chemistry) certified
-
-
-
2021
-
11
-
Received a recognition award for Commercialization of Healthcare Technology honored by KHDI
-
Ranked No. 1 in Global Innovator Festa Startup Audition 2021
-
-
10
-
Awarded the excellence prize in K-innovation showcase of ITS 2021
-
Nominated Finalists Startups 4 in 2021 Medtech Innovator Asia Pacific
-
Declared GMP certification for In vitro diagnostics by MFDS
-
Won Seoul Innovation QuickFire Challenge : Smart surgery
-
-
09
-
Selected as K-innovation company in ITS 2021
-
Awarded the excellence prize in Startup league of Regulatory Free Zone
-
-
05
-
Selected as Corporation Baby Unicorn by Ministry of SMEs and Startups
-
-
04
-
Raised a Series Pre B1
-
-
03
-
Declared Manufacturing of cCeLL - Ex vivo(In-vitro Diagnostics)
-
-
-
2020
-
12
-
Signed MOU with SAMSUNG SEOUL HOSPITAL SMART HEALTHCARE LAB Center for Medical Research
-
Declared Manufacturing of cCeLL - V-Cube(In-vitro Diagnostics)
-
-
11
-
Permitted Manufacturing of In-vitro Diagnostics by MFDS (Korea)
-
-
09
-
Awarded the grand prize in KOREA BUSINESS INCUBATION ASSOCIATION Superior Technique Award
-
-
07
-
Signed MOU with THE CATHOLIC UNIV. OF KOREA YEOUIDO ST. MARY'S HOSPITAL
-
-
05
-
Signed MOU with KOREA UNIVERSITY ANAM HOPITAL
-
-
-
2019
-
12
-
Received the SMEs & Startups Minister’s Award for Woman Entrepreneur
-
-
11
-
Ranked 2nd (The excellence award) in K-Startup 2019
-
Top 60 startups in Slush 2019 showcase
-
-
07
-
Raised a Series A
-
-
01
-
Top 20 startups in MedTech Innovator Asia Pacific 2019 Showcase
-
-
-
2018
-
12
-
Awarded grand prize winner in Daejeon Demo day
-
Top 100 startups in Slush 2018 Helsinki
-
-
06
-
Established Corporate R&D Center, Certification of Venture Business
-
-
-
2017
-
12
-
Selected to TIPS program
-
-
-
2016
-
12
-
VPIX Medical, Inc. was founded
-
-